본문 바로가기

Awareness and attitude of the public toward personalized medicine in Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
PLOS ONE13(2) · 2018
피인용
Web of Science 23Scopus 23
FWCI (Scopus)
0.74
JCR IF
JCR 2017 2.766
ISSN
1932-6203

저자

  1. Lee, Iyn-Hyang제1저자College of Pharmacy, Yeungnam University, Gyeongbuk-do, South Korea
  2. Kang, Hye-YoungCollege of Pharmacy, Yonsei University, Inchon, South Korea
  3. 서혜선College of Pharmacy, Pusan National University, Busan, South Korea
  4. Lee, SukhyangCollege of Pharmacy, Ajou University, Kyeonggi-do, South Korea
  5. Oh, Eun SilDepartment of Pharmaceutical Medicine and Regulatory Sciences, Colleges of Medicine and Pharmacy, Yonsei University, Incheon, South Korea
  6. Jeong, Hotcherl교신저자College of Pharmacy, Ewha Womans University, Seoul, South Korea

초록

Objectives As personalized medicine (PM) is expected to greatly improve health outcomes, efforts have recently been made for its clinical implementation in Korea. We aimed to evaluate public awareness and attitude regarding PM. Methods We performed a self-administered questionnaire survey to 703 adults, who participated in the survey on a voluntary basis. The primary outcome measures included public knowledge, attitude, and acceptance of PM. We conducted multinomial multivariate logistic analysis for outcome variables with three response categories and performed multivariate logistic regression analyses for dichotomous outcome variables. Results Only 28% of participants had knowledge that genetic factors can contribute to inter-individual variations in drug response and the definition of PM (199 out of 702). Higher family income was correlated with greater knowledge concerning PM (OR = 3.76, p = 0.034). A majority of respondents preferred integrated pharmacogenomic testing over drug-specific testing and agreed to inclusion of pharmacogenomic testing in the national health examination (64% and 77%, respectively), but only 51% were willing to pay for it. Discussion Our results identify the urgent need for public education as well as the potential health disparities in access to PM. This study helps to frame policies for implementing PM in clinical practice.

키워드

KNOWLEDGEPHARMACOGENOMICSASSOCIATIONPOPULATIONGENETICSGENOMERISK

식별자

Scopus EID
2-s2.0-85042224933
WoS UID
000425369800021